Last reviewed · How we verify
NCT07322653
The Effects of MediDrink Platinum+ and Fava Bean Protein Hydrolysate on Fitness in an Aged Population
NA trial testing MediDrink Platinum+ in Sarcopenia in Elderly in 75 participants. Currently enrolling.
1 October 2026
Quick facts
| Lead sponsor | Nuritas Ltd |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | double |
| Primary purpose | supportive care |
| Enrollment | 75 |
| Start date | 10 September 2025 |
| Primary completion | 1 October 2026 |
| Estimated completion | 2 January 2027 |
| Sites | 2 locations across Hungary |
Drugs / interventions tested
- MediDrink Platinum+
- MediDrink Platinum+ and PeptiStrong
Conditions studied
- Sarcopenia in Elderly — all drugs for Sarcopenia in Elderly →
- Malnourished — all drugs for Malnourished →
- Protein Supplementation — all drugs for Protein Supplementation →
- Muscle Mass — all drugs for Muscle Mass →
Sponsor
Nuritas Ltd
Who can join
60 and older, any sex, with Sarcopenia in Elderly or Malnourished. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Examining the effects of MediDrink Platinum+ containing novel protein blend SRP-01 alone or when combined with PeptiStrong on clinical responses in elderly adults with sarcopenia
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07322653
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Sarcopenia in Elderly
Currently open trials in the same condition.
- NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
- NCT07412379 — Predictive Factors for Functional and Quality of Life Decline in Patients >65 Years With a Gastrointestinal Tract Cancer · recruiting
- NCT06853275 — The Influence of Movement Velocity Biofeedback on Muscle Activation and Self Perception in Older Adults With Sarcopenia · NA · recruiting
- NCT07124338 — Preventing Hospital Associated Disability in Older Patients: Individualized Nutrition and Exercise Strategy, a Feasibili · NA · active not recruiting
- NCT06991855 — Effects of Nutritional Supplementation of Leucine and Polyunsaturated Fatty Acids on Muscle Health in the Elderly · NA · recruiting
Other Nuritas Ltd trials
Trials by the same sponsor.
- NCT07528469 — The Effects of PeptiStrong and Whey on Muscle Function In Older Adults · NA · not yet recruiting
- NCT07258433 — Effects of PeptiSleep on Sleep Quality in Healthy Adults · NA · recruiting
- NCT06894875 — Effects of Lentil Protein Hydrolysate on Blood Pressure Control, Vascular Function and Exercise Performance · NA · recruiting
- NCT06440213 — A Study to Determine the Safety and Tolerability of a Range of Doses of PeptiControl in Pre-diabetic Individuals · NA · completed
- NCT06267586 — Effects of PeptiSleep in Healthy Males and Females With Mild to Moderate Sleep Impairment · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07322653 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Nuritas Ltd
- Last refreshed: 7 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07322653.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing